ENTA vs IT · rev $65.3M vs P/E 16, rev $6.27B
Enanta Pharmaceuticals Inc (ENTA) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. Revenue was down 3.4% from 2024-09-30 to 2025-09-30. ENTA currently screens at market cap $328.0M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ENTA currently screens at market cap $328.0M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ENTA and IT stock pages for the full models.
Not investment advice.